Fosun Pharmaceutical's Seven Drugs Included in China's Insurance Drug List

MT Newswires14:51

Fosun Henlius' (02696.HK) Fotonine has been included in the updated National Medical Insurance Drug List.

Henlius Biotech (02696.HK) announced that Fruquintinib (Citrate Votrient Capsules) has been included in the Class B range of the 'National Basic Medical Insurance, Maternity Insurance, and Work-related Injury Insurance Drug List (2025).' The approved indication for inclusion is its use in combination with fulvestrant for adult patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer who have experienced disease progression after prior endocrine therapy. The updated national medical insurance drug list will be officially implemented starting January 1, 2026.

AASTOCKSDec 7 21:43

19+114! The National Medical Insurance and Commercial Insurance 'Dual Catalog' Released: Success Rate of Innovative Drug Negotiations Increases to 88%

①The 2025 National Medical Insurance Drug Catalogue successfully added 114 new drugs, of which 50 are Class I innovative drugs. The overall success rate was 88%, significantly higher than the 76% in 2024; ②Among the 19 drugs included in the inaugural commercial insurance innovative drug directory are not only cancer treatments such as CAR-T, but also rare disease treatments for neuroblastoma and Gaucher's disease.

cls.cnDec 7 18:03

Nearly half of the newly added drugs are Class 1 new drugs! The 2025 National Reimbursement Drug List results unveiled: All five CAR-T therapies achieve commercial insurance breakthroughs, marking the entry of innovative drug payment into the 'value era'.

This morning, at the 2025 High-Quality Development Conference for Innovative Pharmaceuticals held in Baiyun District, Guangzhou, the highly anticipated annual National Reimbursement Drug List (NRDL) negotiation results for 2025 were officially announced.

Zhitong FinanceDec 7 16:08

Express News | Fosun Pharma: Multiple drugs from the company have been newly included in the National Medical Insurance Catalogue and the commercial insurance innovative drug list.

BreakingsDec 7 15:51

Express News | Multiple drugs for rare diseases have been included in the 2025 medical insurance catalog and the commercial insurance innovative drug catalog.

BreakingsDec 7 12:07